QRPH - Quality Outcome Reporting for EMS (QORE)
0.1.0 - ci-build

QRPH - Quality Outcome Reporting for EMS (QORE), published by IHE Quality, Research and Public Health Committee. This guide is not an authorized publication; it is the continuous build for version 0.1.0 built by the FHIR (HL7® FHIR® Standard) CI Build. This version is based on the current content of https://github.com/IHE/QRPH.QORE/ and changes regularly. See the Directory of published versions

## : Example of an Opioid measure - XML Representation

Unknown as of 2024-10-23

Raw xml | Download

    <Measure xmlns="http://hl7.org/fhir">
      <id value="example-IHE-QORE-Opioid-11"/>
      <meta>
        <security>
          <system value="http://terminology.hl7.org/CodeSystem/v3-ActReason"/>
          <code value="HTEST"/>
        </security>
      </meta>
      <text>
        <status value="generated"/>
        <div xmlns="http://www.w3.org/1999/xhtml"><p class="res-header-id"><b>Generated Narrative: Measure example-IHE-QORE-Opioid-11</b></p><a name="example-IHE-QORE-Opioid-11"> </a><a name="hcexample-IHE-QORE-Opioid-11"> </a><a name="example-IHE-QORE-Opioid-11-en-US"> </a><p><b>url</b>: <a href="Measure-example-IHE-QORE-Opioid-11.html">Measure Percentage of suspected opioid OD patients experiencing who exhibit adverse effects after naloxone administration</a></p><p><b>version</b>: 0.1.0</p><p><b>title</b>: Percentage of suspected opioid OD patients experiencing who exhibit adverse effects after naloxone administration</p><p><b>status</b>: Unknown</p><p><b>date</b>: 2024-10-23 20:00:04+0000</p><p><b>publisher</b>: IHE Quality, Research and Public Health Committee</p><p><b>contact</b>: <a href="https://www.ihe.net/ihe_domains/quality_research_and_public_health/">https://www.ihe.net/ihe_domains/quality_research_and_public_health/</a>, <a href="mailto:qrph@ihe.net">qrph@ihe.net</a>, IHE Quality, Research and Public Health Committee: <a href="mailto:qrph@ihe.net">qrph@ihe.net</a></p><p><b>jurisdiction</b>: <span title="Codes:{http://unstats.un.org/unsd/methods/m49/m49.htm 001}">Global (Whole world)</span></p><p><b>copyright</b>: </p><div><p>IHE http://www.ihe.net/Governance/#Intellectual_Property</p>
    </div><p><b>type</b>: <span title="Codes:">outcome</span></p><p><b>rationale</b>: </p><div><p>Patients an opioid overdose may become agitated or violent following naloxone administration due to acute opioid withdrawal. Therefore, the goal is to use the lowest dose possible to restore spontaneous respirations but avoid precipitating withdrawal</p>
    </div><p><b>definition</b>: </p><div><p>Measures the percentage of suspected opioid OD patients experiencing who exhibit adverse effects after naloxone administration.</p>
    </div><blockquote><p><b>group</b></p><blockquote><p><b>population</b></p><p><b>code</b>: <span title="Codes:">numerator</span></p><p><b>description</b>: All patients who were given Narcan, and developed adverse effects.</p><h3>Criteria</h3><table class="grid"><tr><td style="display: none">-</td><td><b>Language</b></td></tr><tr><td style="display: none">*</td><td>CQL</td></tr></table></blockquote><blockquote><p><b>population</b></p><p><b>code</b>: <span title="Codes:">denominator</span></p><p><b>description</b>: All patients who were given Narcan.</p><h3>Criteria</h3><table class="grid"><tr><td style="display: none">-</td><td><b>Language</b></td></tr><tr><td style="display: none">*</td><td>CQL</td></tr></table></blockquote></blockquote></div>
      </text>
      <url
           value="http://profiles.ihe.net/QRPH/QORE/Measure/example-IHE-QORE-Opioid-11"/>
      <version value="0.1.0"/>
      <title
             value="Percentage of suspected opioid OD patients experiencing who exhibit adverse effects after naloxone administration"/>
      <status value="unknown"/>
      <date value="2024-10-23T20:00:04+00:00"/>
      <publisher value="IHE Quality, Research and Public Health Committee"/>
      <contact>
        <telecom>
          <system value="url"/>
          <value
                 value="https://www.ihe.net/ihe_domains/quality_research_and_public_health/"/>
        </telecom>
      </contact>
      <contact>
        <telecom>
          <system value="email"/>
          <value value="qrph@ihe.net"/>
        </telecom>
      </contact>
      <contact>
        <name value="IHE Quality, Research and Public Health Committee"/>
        <telecom>
          <system value="email"/>
          <value value="qrph@ihe.net"/>
        </telecom>
      </contact>
      <jurisdiction>
        <coding>
          <system value="http://unstats.un.org/unsd/methods/m49/m49.htm"/>
          <code value="001"/>
        </coding>
      </jurisdiction>
      <copyright
                 value="IHE http://www.ihe.net/Governance/#Intellectual_Property"/>
      <type>
        <coding>
          <code value="outcome"/>
        </coding>
      </type>
      <rationale
                 value="Patients an opioid overdose may become agitated or violent following naloxone administration due to acute opioid withdrawal. Therefore, the goal is to use the lowest dose possible to restore spontaneous respirations but avoid precipitating withdrawal"/>
      <definition
                  value="Measures the percentage of suspected opioid OD patients experiencing who exhibit adverse effects after naloxone administration."/>
      <group>
        <population>
          <code>
            <coding>
              <code value="numerator"/>
            </coding>
          </code>
          <description
                       value="All patients who were given Narcan, and developed adverse effects."/>
          <criteria>
            <language value="text/cql"/>
          </criteria>
        </population>
        <population>
          <code>
            <coding>
              <code value="denominator"/>
            </coding>
          </code>
          <description value="All patients who were given Narcan."/>
          <criteria>
            <language value="text/cql"/>
          </criteria>
        </population>
      </group>
    </Measure>